11. AB0174 Increased Proportion of CD38+Igd+ B Cells Contributes to Pathogenesis of Primary SjÖGren's Syndrome. (10th June 2014) Authors: Ishioka, E.; Yoshimoto, K.; Nishikawa, A.; Suzuki, K.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 860 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. AB0188 Activated platelets are increased in circulation of patients with systemic sclerosis and associated with clinical characteristics. (12th June 2018) Authors: Yasuoka, H.; Sakata, K.; Yoshimoto, K.; Yamaoka, K.; Kuwana, M.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. AB0190 Impaired activation of ataxia-telangiectasia mutated protein kinase in immune cells is associated with clinical features in patients with systemic sclerosis. (12th June 2018) Authors: Sakata, K.; Yasuoka, H.; Yoshimoto, K.; Yamaoka, K.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. AB0294 Long-term comprehensive disease control with certolizumab pegol regardless of concomitant dmards: results from the japanese cohort. (23rd January 2014) Authors: Tanaka, Y.; Yamamoto, K.; Takeuchi, T.; Yamanaka, H.; Ishiguro, N.; Eguchi, K.; Watanabe, A.; Origasa, H.; Okamoto, T.; Shoji, T.; Miyasaka, N.; Koike, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A876 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. AB0319 Treatment with tocilizumab improved rheumatoid arthritis patients clinically and structurally regardless of the prior use of anti-tnf biologics in daily clinical practice. (23rd January 2014) Authors: Izumi, K.; Kaneko, Y.; Yasuoka, H.; Seta, N.; Kameda, H.; Kuwana, M.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. AB0341 Favorable Effects of Sirukumab Treatment on Physical Function and Reductions in Morning Stiffness in Patients with Active Rheumatoid Arthritis and An Inadequate Response To Disease-Modifying Anti-Rheumatic Drugs. (15th July 2016) Authors: Thorne, C.; Takeuchi, T.; Karpouzas, G.; McQuarrie, K.; Sheng, S.; Xu, W.; Peterson, S.; Ganguly, R.; Han, C.; Fei, K.; Hsu, B. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. AB0347 Validation of the clinical remission criteria in rheumatoid arthritis at keio immunotherapy center. (23rd January 2014) Authors: Kaneko, Y.; Kuwana, M.; Kameda, H.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. AB0358 Serum GM-CSF Levels Are Significantly Associated with Interstitial Pneumonia in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Cohort Study (Keio First-Bio Cohort Study). (9th June 2015) Authors: Izumi, K.; Hashizume, M.; Yoshimoto, K.; Kaneko, Y.; Yasuoka, H.; Suzuki, K.; Yamaoka, K.; Takeuchi, T. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. AB0378 Improvements in Measures of Work Productivity/interference and General Health Status with Sirukumab Treatment in Patients with Active Rheumatoid Arthritis despite Disease-Modifying Anti-Rheumatic Drug Treatment. (15th July 2016) Authors: Takeuchi, T.; Karpouzas, G.; Thorne, C.; McQuarrie, K.; Sheng, S.; Xu, W.; Peterson, S.; Ganguly, R.; Han, C.; Fei, K.; Hsu, B. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. AB0384 MEDICATION USE IN SYSTEMIC LUPUS ERYTHEMATOSUS – DATA FROM A MULTICENTRE COHORT STUDY. (2nd June 2020) Authors: Kandane-Rathnayake, R.; Louthrenoo, W.; Luo, S. F.; Wu, Y. J.; Chen, Y. H.; Golder, V.; Lateef, A.; Cho, J.; Navarra, S.; Zamora, L.; Hamijoyo, L.; Sockalingam, S.; An, Y.; Li, Z.; Katsumata, Y.; Harigai, M.; Hao, Y.; Zhang, Z.; Chan, M.; Kikuchi, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗